Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19

Sengupta, Vikram; Sengupta, Sascha; Lazo, Angel; Woods, Peter; Nolan, Anna; J. Bremer, Nicholas

doi:10.1089/scd.2020.0080

Public

Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19

Published in Stem Cells and Development • May 8, 2020

Authors:

Vikram Sengupta

Sascha Sengupta

Angel Lazo

Abstract

This prospective nonrandomized open-label cohort study addresses the safety and efficacy of exosomes (ExoFlo™) derived from allogeneic bone marrow mesenchymal stem cells as treatment for severe COVID-19. During April 2020, ExoFlo was provided to 24 SARS-CoV-2 polymerase chain reaction-positive patie...

Subject

Fraction of inspired oxygen

Internal medicine

Gastroenterology

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!